Beyond the Joint: Perineural Injection Therapy for Chronic Pain Restoration
Presentation Description:
Many chronic pain conditions are driven not only by joints, muscles, or structural abnormalities, but by irritated peripheral nerves and persistent neurogenic inflammation. In this hands-on workshop, Dr. Brenden Cochran introduces Perineural Injection Therapy (PIT), a practical approach for identifying and treating these often-overlooked pain generators. Attendees will learn the science behind peripheral nerve dysfunction, explore common treatment targets, and gain practical experience through live demonstrations and guided injection training. Designed for clinicians seeking effective, minimally invasive solutions for chronic pain, this workshop provides actionable techniques that can be immediately incorporated into clinical practice to improve patient outcomes and functional recovery.
EBOO at the Frontier: New Discoveries & Clinical Pearls
We will review recent discoveries and evolving concepts in EBOO, with a particular emphasis on dialyzer selection, membrane adsorption characteristics, material chemistry, oxidative stability, and biocompatibility. Attendees will gain insight into how differences in membrane composition may influence blood-material interactions, treatment performance, and clinical decision-making. The presentation will also include preliminary findings from our ongoing glutathione investigation, discuss current approaches to toxicity assessment during EBOO, and share practical clinical pearls developed through real-world experience. Participants will leave with evidence-informed strategies to optimize safety, treatment consistency, and patient outcomes while identifying important areas requiring future research.
Learning Objectives
Differentiate the characteristics of commonly used EBOO dialyzer membranes, including adsorption properties, biocompatibility, oxidative resistance, and chemical stability, and discuss how these factors may influence clinical performance.
Review emerging research and preliminary data regarding glutathione dynamics and toxicity assessment during EBOO, including their potential implications for treatment optimization and patient monitoring.
Apply practical clinical pearls to improve EBOO protocols, enhance treatment consistency, and support safe, evidence-informed implementation in clinical practice.